By | March 30, 2015

Pharmaceutical News Wrap Up: March 2015

Interested in the latest pharmaceutical news? Simmons Hanly Conroy’s pharmaceutical attorneys understand the importance of staying up to date, which is why we’re providing the list of recent news stories below. Read… Read More

By | March 26, 2015

Pelvic Organ Prolapse Patients: Follow These Precautions For TVM Surgery

Pelvic organ prolapse (POP), caused by the weakening of the tissues that hold pelvic organs, may be experienced by 30-50 percent of women. Despite its controversial results, transvaginal surgical mesh is the… Read More

By | March 24, 2015

The Ovarian Cancer Risk Factor You May Not Know

Ovarian cancer is one of the most common cancers among women. According to the American Cancer Society, an average woman’s risk of developing ovarian cancer is 1 in 75. Approximately 21,290 women… Read More

By | March 5, 2015

Testosterone Lawsuit News: FDA Orders Label Warnings on Testosterone Drugs

Testosterone therapy manufacturers must update the labels of all testosterone products to inform men about the increased risk of stroke, heart attack and death in patients taking testosterone, according to a testosterone… Read More

By | March 3, 2015

Xarelto and Internal Bleeding Frequently Asked Questions

Xarelto, an oral anticoagulant drug, is prescribed by doctors to reduce the risk of blood clots that may cause strokes. It is easier to use than many other blood thinners on the… Read More

By | February 27, 2015

Pharmaceutical News Wrap Up: February 2015

The pharmaceutical attorneys at Simmons Hanly Conroy know it’s essential to stay updated on the latest headlines, which is why we’re providing the list below. Read about recent U.S. Food and Drug… Read More

By | February 25, 2015

New Research Links Zofran to Increased Risk of Birth Defects in Pregnant Women

Morning sickness is a common side effect of pregnancy. According to the American Pregnancy Association, more than 50 percent of pregnant women experience some degree of morning sickness, vomiting or nausea. This… Read More

By | February 24, 2015

Shareholder Jayne Conroy Plays Major Role on Corn Litigation Plaintiff’s Executive Committee

Earlier this year, my colleague, Shareholder Jayne Conroy was appointed to the Plaintiffs’ Executive Committee (PEC) for the pending multidistrict litigation (MDL) against Syngenta Seeds Inc. concerning its genetically modified corn. Farmers… Read More

By | February 10, 2015

Infographic: Talcum Powder and Ovarian Cancer

Studies concerning talcum powder use and increased ovarian cancer risk have gained much attention over the past year. Specifically, we’ve learned that genital use of talcum powder products (like Johnson’s® baby powder… Read More

By | February 4, 2015

Talcum Powder and Ovarian Cancer Frequently Asked Questions

Talcum powder use is prevalent, especially among women. For years, it has been advertised as a safe and healthy way to stay fresh. But, many women don’t know the health risk it… Read More